HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDTIDE

21.520

+0.8003.86%

Volume:70.60K

Turnover:1.50M

Market Cap:3.05B

PE:11.30

High:22.000

Open:20.700

Low:20.700

Close:20.720

52wk High:33.180

52wk Low:17.640

Shares:141.80M

HK Float Shares:141.80M

Volume Ratio:0.84

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.905

ROE:10.89%

ROA:6.82%

PB:1.60

PE(LYR):11.30

PS:4.74

Loading ...

Overview Company News Filings

Medtide completes U.S. FDA Pre-License Inspection for Hepcludex API at Hangzhou facility

Bulletin Express

MEDTIDE (03880) Issues Profit Warning, Expects First-Half Profit to Drop Approximately 44% to 51.6% Year-on-Year

MEDTIDE's HEPCLUDEX® Active Ingredient Passes FDA Pre-License Inspection

MEDTIDE Appoints New CFO and Revamps Key Management Positions

Medtide Unit Chinese Peptide Completes US FDA Pre-license Inspection for Hepcludex API Facility

Medtide Names Ding Lijun as CFO

Medtide - Subsidiary Completes U.S. FDA Pre-License Inspection at Hangzhou Facility

THOMSON REUTERS

Medtide Expects H1 Profit to Fall 44%-52% to RMB 49.4 million-RMB 57.1 Million

Medtide - Appoints Ding Lijun as Chief Financial Officer Effective July 31, 2026

THOMSON REUTERS

Medtide - Sees H1 2026 Revenue at Rmb229.8 Mln–RMB239.2 Mln, Down 5.7%–9.4% Y/Y

THOMSON REUTERS

Precision Peptide Closes $2 Million Share Offering Under Canadian LIFE Exemption

Precision Peptide Receives 20,000-unit Production Run of Bpc-157 Transdermal Patches

Precision Peptide Signs Exclusive Strategic Marketing Partnership with Mma.inc

MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant

Bulletin Express

Medtide Updates Articles of Association: Sets Governance, Share Capital at 141.80 Million H Shares

Bulletin Express

Medtide amends articles of association, scraps supervisory committee

Precision Peptide plans non-brokered private placement of up to 4,000,000 shares at $0.5 each, targeting up to $2 million gross proceeds

Medtide Says CPC Scientific Enters Construction Contracts For Rocklin Site On Aug 7, 2025

MEDTIDE's Subsidiary Signs Construction Contract with Market One Builders for Rocklin Campus

Medtide - Cpc Scientific Enters Construction Contracts for Rocklin Site at Max Price of $22.7 Mln on Aug 7, 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/03880/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":21.52,"timestamp":1790755159586,"preClose":20.72,"halted":0,"volume":70600,"delay":0,"changeRate":0.038610038610038644,"floatShares":141800000,"shares":141800000,"eps":1.904712921476157,"marketStatus":"Closed National Day","change":0.8,"latestTime":"09-30 15:59:19","open":20.7,"high":22,"low":20.7,"amount":1504850,"amplitude":0.062741,"askPrice":21.88,"askSize":300,"bidPrice":21.06,"bidSize":400,"shortable":0,"etf":0,"ttmEps":1.39163350745847,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":20.72,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0.8372865259254526,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"6.82%","roe":"10.89%","lyrEps":1.904711,"volumeRatio":0.8372865259254526,"shares":141800000,"dividePrice":0,"high":22,"amplitude":0.062741,"preClose":20.72,"low":20.7,"week52Low":17.64,"pbRate":"1.60","psRate":"4.74","week52High":33.18,"institutionHeld":0,"latestPrice":21.52,"committee":0.142857,"eps":1.9047107658505964,"divideRate":0,"volume":70600,"delay":0,"ttmEps":1.3916319325015694,"open":20.7,"prevYearClose":30.48,"prevWeekClose":22.78,"prevMonthClose":21.52,"prevQuarterClose":21.52,"fiveDayClose":22.6,"twentyDayClose":21.22,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-09-30","current":15.451615,"percent":0.380645,"low":11.049775,"twenty":12.660198,"median":29.696692,"eighty":37.085683,"high":89.502411,"avg":31.424369,"sd":21.190558,"marketCap":3051536000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-27","current":25.407751,"twenty":30.961293,"median":35.900465,"eighty":70.436098,"marketCap":3181992000},{"date":"2026-04-02","current":12.694395,"twenty":30.374151,"median":35.877946,"eighty":69.313609,"marketCap":3139452000},{"date":"2026-04-10","current":12.836208,"twenty":29.799581,"median":35.844414,"eighty":69.013634,"marketCap":3199008000},{"date":"2026-04-17","current":12.660198,"twenty":28.991894,"median":35.202659,"eighty":68.828913,"marketCap":3156468000},{"date":"2026-04-24","current":12.397874,"twenty":27.75939,"median":35.115214,"eighty":68.535434,"marketCap":3091240000},{"date":"2026-04-30","current":12.269611,"twenty":26.785787,"median":34.99421,"eighty":68.377965,"marketCap":3060044000},{"date":"2026-05-08","current":12.363155,"twenty":25.983648,"median":34.594549,"eighty":67.965697,"marketCap":3094076000},{"date":"2026-05-15","current":12.534163,"twenty":25.665008,"median":34.175169,"eighty":67.389311,"marketCap":3145124000},{"date":"2026-05-22","current":12.642172,"twenty":25.399381,"median":33.645975,"eighty":67.311524,"marketCap":3164976000},{"date":"2026-05-29","current":12.270986,"twenty":25.218458,"median":33.406025,"eighty":67.131365,"marketCap":3082732000},{"date":"2026-06-05","current":11.125953,"twenty":24.642571,"median":33.30501,"eighty":64.550519,"marketCap":2799132000},{"date":"2026-06-12","current":13.017265,"twenty":13.007169,"median":33.187074,"eighty":42.637728,"marketCap":3272744000},{"date":"2026-06-18","current":12.671021,"twenty":12.943368,"median":33.126975,"eighty":41.844528,"marketCap":3193336000},{"date":"2026-06-26","current":12.518344,"twenty":12.901138,"median":33.023157,"eighty":41.133711,"marketCap":3139452000},{"date":"2026-07-03","current":12.429887,"twenty":12.724861,"median":32.858736,"eighty":40.911062,"marketCap":3119600000},{"date":"2026-07-10","current":13.463401,"twenty":12.685266,"median":32.845563,"eighty":39.914225,"marketCap":3374840000},{"date":"2026-07-17","current":13.021079,"twenty":12.724861,"median":32.687847,"eighty":39.039678,"marketCap":3275580000},{"date":"2026-07-24","current":12.950528,"twenty":12.774507,"median":32.49883,"eighty":38.697228,"marketCap":3258564000},{"date":"2026-07-31","current":12.667228,"twenty":12.718655,"median":32.350921,"eighty":38.507791,"marketCap":3193336000},{"date":"2026-08-07","current":11.576024,"twenty":12.668745,"median":32.105235,"eighty":38.341571,"marketCap":2923916000},{"date":"2026-08-14","current":12.133289,"twenty":12.639428,"median":31.958711,"eighty":38.254613,"marketCap":3068552000},{"date":"2026-08-21","current":13.057601,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"marketCap":3309612000},{"date":"2026-08-28","current":15.462922,"twenty":12.621641,"median":31.567575,"eighty":37.94638,"marketCap":3048700000},{"date":"2026-09-04","current":15.370447,"twenty":12.633554,"median":31.132408,"eighty":37.865542,"marketCap":3031684000},{"date":"2026-09-11","current":13.30358,"twenty":12.639428,"median":30.942991,"eighty":37.772667,"marketCap":2627554000},{"date":"2026-09-18","current":14.784774,"twenty":12.648608,"median":30.467091,"eighty":37.452165,"marketCap":2923916000},{"date":"2026-09-25","current":16.364708,"twenty":12.659036,"median":29.807701,"eighty":37.099262,"marketCap":3230204000},{"date":"2026-09-30","current":15.43076,"twenty":12.660198,"median":29.696692,"eighty":37.085683,"marketCap":3051536000}],"updateTime":1790814897072},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148679402","title":"Medtide completes U.S. FDA Pre-License Inspection for Hepcludex API at Hangzhou facility","url":"https://stock-news.laohu8.com/highlight/detail?id=1148679402","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148679402?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:47","pubTimestamp":1785487636,"startTime":"0","endTime":"0","summary":"Medtide Inc. (MEDTIDE) announced that its wholly owned subsidiary Chinese Peptide Company has passed a U.S. Food and Drug Administration Pre-License Inspection (PLI) for the commercial production of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120383613","title":"MEDTIDE (03880) Issues Profit Warning, Expects First-Half Profit to Drop Approximately 44% to 51.6% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1120383613","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120383613?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:44","pubTimestamp":1785487468,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has issued an announcement regarding its financial performance for the six months ending June 30, 2026, compared to the same period in 2025. The board anticipates that revenue will...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107085569","title":"MEDTIDE's HEPCLUDEX® Active Ingredient Passes FDA Pre-License Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1107085569","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107085569?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:44","pubTimestamp":1785487449,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced that its wholly-owned subsidiary, Zhongtai Shenghua Co., Ltd. (\"Zhongtai Shenghua\"), has successfully completed a Pre-License Inspection (PLI) by the U.S. Food and Drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK4585","BK4588","03880","LABU","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112713365","title":"MEDTIDE Appoints New CFO and Revamps Key Management Positions","url":"https://stock-news.laohu8.com/highlight/detail?id=1112713365","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112713365?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:38","pubTimestamp":1785487097,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356459","title":"Medtide Unit Chinese Peptide Completes US FDA Pre-license Inspection for Hepcludex API Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356459?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:35","pubTimestamp":1785486919,"startTime":"0","endTime":"0","summary":"Medtide unit Chinese Peptide completes US FDA pre-license inspection for Hepcludex API facilityChinese Peptide, a wholly owned Medtide subsidiary, cleared a US FDA pre-license inspection for Hepcludex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8fHx2L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356455","title":"Medtide Names Ding Lijun as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356455?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:35","pubTimestamp":1785486901,"startTime":"0","endTime":"0","summary":"Medtide names Ding Lijun as CFONamed Ding Lijun as chief financial officer effective July 31, 2026; she was CFO of Inventronics (Hangzhou) from Feb 2025 to Jul 2026.Ding previously served as finance v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6fMHMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU0502904849.HKD","LU2488822045.USD","LU1969619763.USD","300582","LU2242644610.SGD","LU2097828805.USD","BK1161","KURE","LU2328871848.SGD","LU0455707207.USD","LU2097828474.EUR","LU2097828557.USD","01801","03880","300577","BK1583","HK0000165453.HKD","LU2097828631.EUR","BK1141","BK1589","BK0214","BK0247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356956","title":"Medtide - Subsidiary Completes U.S. FDA Pre-License Inspection at Hangzhou Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356956?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:33","pubTimestamp":1785486838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655919356","title":"Medtide Expects H1 Profit to Fall 44%-52% to RMB 49.4 million-RMB 57.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655919356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655919356?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:33","pubTimestamp":1785486803,"startTime":"0","endTime":"0","summary":"Medtide expects H1 profit to fall 44%-52% to RMB 49.4 million-RMB 57.1 millionFlagged weaker 1H 2026 results: revenue RMB 229.8 million–RMB 239.2 million, down 5.7%–9.4% from RMB 253.8 million.Profit ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL67GtmB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655635667","title":"Medtide - Appoints Ding Lijun as Chief Financial Officer Effective July 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655635667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655635667?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:32","pubTimestamp":1785486768,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655735695","title":"Medtide - Sees H1 2026 Revenue at Rmb229.8 Mln–RMB239.2 Mln, Down 5.7%–9.4% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2655735695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655735695?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:32","pubTimestamp":1785486737,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0KZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145200","title":"Precision Peptide Closes $2 Million Share Offering Under Canadian LIFE Exemption","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145200?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:03","pubTimestamp":1784113410,"startTime":"0","endTime":"0","summary":"Precision Peptide closes $2 million share offering under Canadian LIFE exemptionThe Precision Peptide Company closed a non-brokered LIFE private placement, raising $2 million through 4,000,000 common ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL1jpgD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774741","title":"Precision Peptide Receives 20,000-unit Production Run of Bpc-157 Transdermal Patches","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774741","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651774741?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:02","pubTimestamp":1784026973,"startTime":"0","endTime":"0","summary":"Precision Peptide receives 20,000-unit production run of BPC-157 transdermal patchesThe Precision Peptide Company received about 20,000 BPC-157 transdermal patches, marking its shift from testing to c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLkr8b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986599","title":"Precision Peptide Signs Exclusive Strategic Marketing Partnership with Mma.inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986599","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649986599?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:05","pubTimestamp":1783508707,"startTime":"0","endTime":"0","summary":"Precision Peptide signs exclusive strategic marketing partnership with MMA.INCThe Precision Peptide Company signed an exclusive strategic marketing agreement with Mixed Martial Arts Group (MMA.INC) in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLGHNRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK4192","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108336724","title":"MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1108336724","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108336724?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:23","pubTimestamp":1783329818,"startTime":"0","endTime":"0","summary":"MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138756410","title":"Medtide Updates Articles of Association: Sets Governance, Share Capital at 141.80 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1138756410","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138756410?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:43","pubTimestamp":1781783039,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880, “Medtide”) has released a comprehensive revision of its Articles of Association, approved at the 18 June 2026 annual general meeting. The document reshapes the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644088879","title":"Medtide amends articles of association, scraps supervisory committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2644088879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644088879?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:29","pubTimestamp":1781782172,"startTime":"0","endTime":"0","summary":"Medtide shareholders passed bylaw amendments at the June 18, 2026 annual meeting.The changes take effect immediately, abolishing the supervisory committee.Current supervisory committee members cease to hold office from the meeting date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL310rzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642826232","title":"Precision Peptide plans non-brokered private placement of up to 4,000,000 shares at $0.5 each, targeting up to $2 million gross proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2642826232","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642826232?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:01","pubTimestamp":1781211680,"startTime":"0","endTime":"0","summary":"Precision Peptide plans non-brokered private placement of up to 4,000,000 shares at $0.5 each, targeting up to $2 million gross proceeds. The Precision Peptide Company launched a non-brokered private placement of 3,000,000 to 4,000,000 common shares at $0.5 each.Gross proceeds targeted at $1.5 million to $2 million.Net proceeds earmarked for working capital, marketing, inventory, and products.Closing expected on or about June 25, 2026, with the financing potentially completed in tranches.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL12Pxwn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642491185","title":"Medtide Says CPC Scientific Enters Construction Contracts For Rocklin Site On Aug 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2642491185","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642491185?lang=en_us&edition=fundamental","pubTime":"2026-06-10 01:11","pubTimestamp":1781025066,"startTime":"0","endTime":"0","summary":"June 9 (Reuters) - Medtide <3880.HK>::*CPC SCIENTIFIC ENTERS CONSTRUCTION CONTRACTS FOR ROCKLIN SITE AT MAX PRICE OF $22.7 MILLION ON AUG 7, 2025*Further company coverage: 3880.HK* ((Reuters.Briefs@th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nRSD62NMhC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149779263","title":"MEDTIDE's Subsidiary Signs Construction Contract with Market One Builders for Rocklin Campus","url":"https://stock-news.laohu8.com/highlight/detail?id=1149779263","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149779263?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:54","pubTimestamp":1781009664,"startTime":"0","endTime":"0","summary":"The company's wholly-owned subsidiary, CPC Scientific Inc., has entered into a construction contract with Market One Builders for the development of the Rocklin campus, with a guaranteed maximum...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642146037","title":"Medtide - Cpc Scientific Enters Construction Contracts for Rocklin Site at Max Price of $22.7 Mln on Aug 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2642146037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642146037?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:39","pubTimestamp":1781008773,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42H0K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":58,"code":"91000000","status":"200"}]}}